- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Cystic fibrosis
- Meeting Date: December 2021
- Public Summary Document (PSD) December 2021 PBAC Meeting - (PDF 719KB)
- Public Summary Document (PSD) December 2021 PBAC Meeting - (Word 295KB)
Elexacaftor/tezecaftor/ivacaftor – December 2021
Elexacaftor/tezacaftor/ivacaftor: Pack containing 56 tablets of elexacaftor 100 mg with tezacaftor 50 mg and ivacaftor 75 mg and 28 tablets of ivacaftor 150 mg; Trikafta®
Last updated
1 April 2022